Luo Ning, Chen Gui-Bing, Zhang Teng, Zhao Jie, Fu Jing-Nan, Lu Ning, Ma Tao
Department of General Surgery, Tianjin Medical University General Hospital.
Department of Respiratory and Intensive Care Medicine, Tianjin Medical University General Hospital.
Biol Pharm Bull. 2023;46(2):187-193. doi: 10.1248/bpb.b22-00563.
Endoplasmic reticulum (ER) dysfunction is characterized by ER stress, which can be triggered by sepsis. Recent studies have reported that lessening ER stress is a promising therapeutic approach to improving the outcome of sepsis. Genipin is derived from gardenia fruit, which is a traditional Chinese medicinal herb for anti-inflammation. Here, mice were treated with genipin (2.5 mg/kg) intravenously to assess its biological effects and underlying mechanism against polymicrobial sepsis. Furthermore, the present study focused on detecting the levels of ER stress-related proteins, including protein kinase R-like ER kinase (PERK), glucose-regulated protein of 78 kDa (GRP78), phosphorylated-eukaryotic initiation factor 2α (p-eIF2α), and CCAAT/enhancer binding protein (C/EBP) homologous protein (CHOP). The results demonstrated that genipin significantly decreased the serum concentrations of tumor necrosis factor-α and interleukin-6, alleviated histopathological damage to the lungs, livers and spleens, and even improved the survival rates of septic mice. Moreover, sepsis significantly upregulated the protein expression levels of splenic GRP78, PERK, p-eIF2α and CHOP, but their levels were significantly suppressed by genipin. Furthermore, genipin also significantly downregulated cleaved caspase-3 expression levels and reduced sepsis-induced splenocyte apoptosis. In conclusion, genipin potentially improved the survival rate of sepsis and attenuated sepsis-induced organ injury and an excessive inflammatory response in mice. The effects of genipin against sepsis were potentially associated with decreased splenocyte apoptosis via the attenuation of sepsis-induced ER stress to further inhibit ER stress-induced apoptosis.
内质网(ER)功能障碍的特征是内质网应激,脓毒症可引发这种应激。最近的研究报告称,减轻内质网应激是改善脓毒症预后的一种有前景的治疗方法。京尼平源自栀子果实,栀子是一种具有抗炎作用的传统中草药。在此,对小鼠静脉注射京尼平(2.5毫克/千克),以评估其对多重微生物脓毒症的生物学效应及潜在机制。此外,本研究着重检测内质网应激相关蛋白的水平,包括蛋白激酶R样内质网激酶(PERK)、78 kDa葡萄糖调节蛋白(GRP78)、磷酸化真核起始因子2α(p-eIF2α)和CCAAT/增强子结合蛋白(C/EBP)同源蛋白(CHOP)。结果表明,京尼平显著降低了肿瘤坏死因子-α和白细胞介素-6的血清浓度,减轻了肺、肝和脾的组织病理学损伤,甚至提高了脓毒症小鼠的存活率。此外,脓毒症显著上调了脾脏GRP78、PERK、p-eIF2α和CHOP的蛋白表达水平,但京尼平显著抑制了它们的水平。此外,京尼平还显著下调了裂解的半胱天冬酶-3的表达水平,并减少了脓毒症诱导的脾细胞凋亡。总之,京尼平可能提高脓毒症小鼠的存活率,减轻脓毒症诱导的器官损伤和过度炎症反应。京尼平抗脓毒症的作用可能与通过减轻脓毒症诱导的内质网应激以进一步抑制内质网应激诱导的凋亡从而降低脾细胞凋亡有关。